Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function

Journal of General Virology

Volumn 84, Issue 12, 2003, Pages 3381-3392

  Kato, Kentaro ^a,b   Yokoyama, Akihiko ^a   Tohya, Yukinobu ^b   Akashi, Hiroomi ^b   Nishiyama, Yukihiro ^c   Kawaguchi, Yasushi ^a,c,d  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; CELL NUCLEUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; PHOSPHOPROTEIN; PROTEIN KINASE; SERINE; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; EPSTEIN BARR VIRUS; GENE OVEREXPRESSION; HERPES VIRUS; IN VITRO STUDY; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; PROTEIN TARGETING;

ALANINE; AMINO ACID SUBSTITUTION; ANIMALS; CDC2 PROTEIN KINASE; CELL LINE; CELL TRANSFORMATION, VIRAL; ENZYME ACTIVATION; HERPESVIRUS 4, HUMAN; MUTATION; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; SERINE; SPODOPTERA; VIRAL PROTEINS;

ANIMALIA; DNA VIRUSES; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; MAMMALIA;

EID: 0348013196     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19454-0     Document Type: Article

References (65)

1. Alfieri, C., Birkenbach, M. & Kieff, E. (1991). Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181, 595-608.
2. Allan, G. J., Inman, G. J., Parker, B. D., Rowe, D. T. & Farrell, P. J. (1992). Cell growth effects of Epstein-Barr virus leader protein. J Gen Virol 73, 1547-1551.
3. Bandobashi, K., Maeda, A., Teramoto, N., Nagy, N., Szekely, L., Taguchi, H., Miyoshi, I., Klein, G. & Klein, E. (2001). Intranuclear localization of the transcription coadaptor CBP/p300 and the transcription factor RBP-Jk in relation to EBNA-2 and -5 in B lymphocytes. Virology 288, 275-282.
4. Ben-Sasson, S. A. & Klein, G. (1981). Activation of the Epstein-Barr virus genome by 5-aza-cytidine in latently infected human lymphoid lines. Int J Cancer 28, 131-135.
5. Chee, M. S., Lawrence, G. L. & Barrell, B. G. (1989). Alpha-, beta- and gammaherpesviruses encode a putative phosphotransferase. J Gen Virol 70, 1151-1160.
6. Chen, M. R., Chang, S. J., Huang, H. & Chen, J. Y. (2000). A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro. J Virol 74, 3093-3104.
7. Chung, T. D., Wymer, J. P., Smith, C. C., Kulka, M. & Aurelian, L. (1989). Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). J Virol 63, 3389-3398.
8. Cohen, J. I., Wang, F., Mannick, J. & Kieff, E. (1989). Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci U S A 86, 9558-9562.
9. Cunningham, C., Davison, A. J., Dolan, A., Frame, M. C., McGeoch, D. J., Meredith, D. M., Moss, H. W. & Orr, A. C. (1992). The UL13 virion protein of herpes simplex virus type 1 is phosphorylated by a novel virus-induced protein kinase. J Gen Virol 73, 303-311.
10. de Wind, N., Domen, J. & Berns, A. (1992). Herpesviruses encode an unusual protein-serine/threonine kinase which is nonessential for growth in cultured cells. J Virol 66, 5200-5209.
11. Gershburg, E. & Pagano, J. S. (2002). Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94. J Virol 76, 998-1003.
12. Hammerschmidt, W. & Sugden, B. (1989). Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340, 393-397.
13. Han, I., Harada, S., Weaver, D., Xue, Y., Lane, W., Orstavik, S., Skalhegg, B. & Kieff, E. (2001). EBNA-LP associates with cellular proteins including DNA-PK and HA95. J Virol 75, 2475-2481.
14. Han, I., Xue, Y., Harada, S., Orstavik, S., Skalhegg, B. & Kieff, E. (2002). Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins. Mol Cell Biol 22, 2136-2146.
15. Hanks, S. K., Quinn, A. M. & Hunter, T. (1988). The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241, 42-52.
16. Harada, S. & Kieff, E. (1997). Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation. J Virol 71, 6611-6618.
17. He, Z., He, Y. S., Kim, Y., Chu, L., Ohmstede, C., Biron, K. K. & Coen, D. M. (1997). The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. J Virol 71, 405-411.
18. Hudewentz, J., Bornkamm, G. W. & zur Hausen, H. (1980). Effect of the diterpene ester TPA on Epstein-Barr virus antigen- and DNA synthesis in producer and nonproducer cell lines. Virology 100, 175-178.
19. Igarashi, M., Kawaguchi, Y., Hirai, K. & Mizuno, F. (2003). Physical interaction of Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) with human oestrogen-related receptor 1 (hERR1): hERR1 interacts with a conserved domain of EBNA-LP that is critical for EBV-induced B-cell immortalization. J Gen Virol 84, 319-327.
20. Jiang, W. Q., Szekely, L., Wendel-Hansen, V., Ringertz, N., Klein, G. & Rosen, A. (1991). Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5. Exp Cell Res 197, 314-318.
21. Kato, K., Kawaguchi, Y., Tanaka, M. & 10 other authors (2001). Epstein-Barr virus-encoded protein kinase BGLF4 mediates hyperphosphorylation of cellular elongation factor 1δ (EF-1δ : EF-1δ is universally modified by conserved protein kinases of herpesviruses in mammalian cells. J Gen Virol 82, 1457-1463.
22. Kawaguchi, Y., Bruni, R. & Roizman, B. (1997a). Interaction of herpes simplex virus 1 alpha regulatory protein ICP0 with elongation factor 1delta: ICP0 affects translational machinery. J Virol 71, 1019-1024.
23. Kawaguchi, Y., Van Sant, C. & Roizman, B. (1997b). Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3. J Virol 71, 7328-7336.
24. Kawaguchi, Y., Van Sant, C. & Roizman, B. (1998). Eukaryotic elongation factor 1δ is hyperphosphorylated by the protein kinase encoded by the U(L)13 gene of herpes simplex virus 1. J Virol 72, 1731-1736.
25. Kawaguchi, Y., Matsumura, T., Roizman, B. & Hirai, K. (1999). Cellular elongation factor 1δ is modified in cells infected with representative alpha-, beta-, or gammaherpesviruses. J Virol 73, 4456-4460.
26. Kawaguchi, Y., Nakajima, K., Igarashi, M. & 8 other authors (2000). Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP. J Virol 74, 10104-10111.
27. Kawaguchi, Y., Tanaka, M., Yokoymama, A., Matsuda, G., Kato, K., Kagawa, H., Hirai, K. & Roizman, B. (2001). Herpes simplex virus 1 alpha regulatory protein ICP0 functionally interacts with cellular transcription factor BMAL1. Proc Natl Acad Sci U S A 98, 1877-1882.
28. Kawaguchi, Y., Kato, K., Tanaka, M., Kanamori, M., Nishiyama, Y. & Yamanashi, Y. (2003). Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1δ. J Virol 77, 2359-2368.
29. Kaye, K. M., Izumi, K. M. & Kieff, E. (1993). Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci U S A 90, 9150-9154.
30. Kenyon, T. K., Lynch, J., Hay, J., Ruyechan, W. & Grose, C. (2001). Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. J Virol 75, 8854-8858.
31. Kieff, E. & Rickinson, A. B. (2001). Epstein-Barr Virus and its replication. In Fields Virology, 4th edn, pp. 2511-2573. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott-Williams & Wilkins.
32. Kitay, M. K. & Rowe, D. T. (1996a). Cell cycle stage-specific phosphorylation of the Epstein-Barr virus immortalization protein EBNA-LP. J Virol 70, 7885-7893.
33. Kitay, M. K. & Rowe, D. T. (1996b). Protein-protein interactions between Epstein-Barr virus nuclear antigen-LP and cellular gene products: binding of 70-kilodalton heat shock proteins. Virology 220, 91-99.
34. Litchfield, D. W., Lozeman, F. J., Cicirelli, M. F., Harrylock, M., Ericsson, L. H., Piening, C. J. & Krebs, E. G. (1991). Phosphorylation of the beta subunit of casein kinase II in human A431 cells. Identification of the autophosphorylation site and a site phosphorylated by p34cdc2. J Biol Chem 266, 20380-20389.
35. Luka, J., Kallin, B. & Klein, G. (1979). Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94, 228-231.
36. McCann, E. M., Kelly, G. L., Rickinson, A. B. & Bell, A. I. (2001). Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function. J Gen Virol 82, 3067-3079.
37. McGeoch, D. J. & Davison, A. J. (1986). Alphaherpesviruses possess a gene homologous to the protein kinase gene family of eukaryotes and retroviruses. Nucleic Acids Res 14, 1765-1777.
38. Mannick, J. B., Cohen, J. I., Birkenbach, M., Marchini, A. & Kieff, E. (1991). The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J Virol 65, 6826-6837.
39. Mannick, J. B., Tong, X., Hemnes, A. & Kieff, E. (1995). The Epstein-Barr virus nuclear antigen leader protein associates with hsp72/hsc73. J Virol 69, 8169-8172.
40. Marchini, A., Cohen, J. I., Wang, F. & Kieff, E. (1992). A selectable marker allows investigation of a nontransforming Epstein-Barr virus mutant. J Virol 66, 3214-3219.
41. Marin, O., Meggio, F., Draetta, G. & Pinna, L. A. (1992). The consensus sequences for cdc2 kinase and for casein kinase-2 are mutually incompatible. A study with peptides derived from the beta-subunit of casein kinase-2. FEBS Lett 301, 111-114.
42. Matsuda, G., Nakajima, K., Kawaguchi, Y., Yamanashi, Y. & Hirai, K. (2003). Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1. Microbiol Immunol 47, 91-99.
43. Nitsche, F., Bell, A. & Rickinson, A. (1997). Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain. J Virol 71, 6619-6628.
44. Overton, H. A., McMillan, D. J., Klavinskis, L. S., Hope, L., Ritchie, A. J. & Wong-kai-in, P. (1992). Herpes simplex virus type 1 gene UL13 encodes a phosphoprotein that is a component of the virion. Virology 190, 184-192.
45. Peng, R., Gordadze, A. V., Fuentes Panana, E. M., Wang, F., Zong, J., Hayward, G. S., Tan, J. & Ling, P. D. (2000a). Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses. J Virol 74, 379-389.
46. Peng, R., Tan, J. & Ling, P. D. (2000b). Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2. J Virol 74, 9953-9963.
47. Petti, L., Sample, C. & Kieff, E. (1990). Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins. Virology 176, 563-574.
48. Ragona, G., Ernberg, I. & Klein, G. (1980). Induction and biological characterization of the Epstein-Barr virus (EBV) carried by the Jijoye lymphoma line. Virology 101, 553-557.
49. Rickinson, A. B. & Kieff, E. (2001). Epstein-Barr virus. In Fields Virology, 4th edn, pp. 2575-2627. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott-Williams & Wilkins.
50. Saemundsen, A. K., Kallin, B. & Klein, G. (1980). Effect of n-butyrate on cellular and viral DNA synthesis in cells latently infected with Epstein-Barr virus. Virology 107, 557-561.
51. Sinclair, A. J., Palmero, I., Peters, G. & Farrell, P. J. (1994). EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J 13, 3321-3328.
52. Smith, R. F. & Smith, T. F. (1989). Identification of new protein kinase-related genes in three herpesviruses, herpes simplex virus, varicella-zoster virus, and Epstein-Barr virus. J Virol 63, 450-455.
53. 2/M transition. Biochim Biophys Acta 1519, 1-12.
54. Stevenson, D., Colman, K. L. & Davison, A. J. (1994). Characterization of the putative protein kinases specified by varicella-zoster virus genes 47 and 66. J Gen Virol 75, 317-326.
55. Szekely, L., Selivanova, G., Magnusson, K. P., Klein, G. & Wiman, K. G. (1993). EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci U S A 90, 5455-5459.
56. Szekely, L., Jiang, W. Q., Pokrovskaja, K., Wiman, K. G., Klein, G. & Ringertz, N. (1995). Reversible nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 and hsp70 proteins after exposure to heat shock or cell density congestion. J Gen Virol 76, 2423-2432.
57. Szekely, L., Pokrovskaja, K., Jiang, W. Q., de The, H., Ringertz, N. & Klein, G. (1996). The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. J Virol 70, 2562-2568.
58. Tanaka, M., Yokoyama, A., Igarashi, M., Matsuda, G., Kato, K., Kanamori, M., Hirai, K., Kawaguchi, Y. & Yamanashi, Y. (2002). Conserved region CR2 of Epstein-Barr virus nuclear antigen leader protein is a multifunctional domain that mediates self-association as well as nuclear localization and nuclear matrix association. J Virol 76, 1025-1032.
59. Tomkinson, B., Robertson, E. & Kieff, E. (1993). Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 67, 2014-2025.
60. van den Heuvel, S. & Harlow, E. (1993). Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262, 2050-2054.
61. van Zeijl, M., Fairhurst, J., Baum, E. Z., Sun, L. & Jones, T. R. (1997). The human cytomegalovirus UL97 protein is phosphorylated and a component of virions. Virology 231, 72-80.
62. Yokoyama, A., Kawaguchi, Y., Kitabayashi, I., Ohki, M. & Hirai, K. (2001a). The conserved domain CR2 of Epstein-Barr virus nuclear antigen leader protein is responsible not only for nuclear matrix association but also for nuclear localization. Virology 279, 401-413.
63. Yokoyama, A., Tanaka, M., Matsuda, G. & 8 other authors (2001b). Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylation. J Virol 75, 5119-5128.
64. zur Hausen, H., O'Neill, F. J., Freese, U. K. & Hecker, E. (1978). Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature 272, 373-375.
65. zur Hausen, H., Bornkamm, G. W., Schmidt, R. & Hecker, E. (1979). Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc Natl Acad Sci U S A 76, 782-785.